Aticaprant

4 trials

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

1 Sponsors

15 Countries

Phase III

Phase I (Other)

Phase III: 3 Phase I (Other): 1

Sponsors using this IMP

Janssen - Cilag International 4

All trials

4 total

A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in … Ended

2024-511057-22-00 Phase III 9 countries Janssen Cilag International
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended

2024-511557-21-00 Phase III 8 countries Janssen Cilag International
A clinical trial to evaluate the absolute bioavailability and metabolic profile of aticaprant when administered as an oral tablet and a micr… Ended

2022-502969-19-00 Phase I (Other) 1 country Janssen - Cilag International
A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended

2023-508163-74-00 Phase III 11 countries Janssen Cilag International

Showing 1–4 of 4 trials

← All drugs A–Z